AGC Biologics to Manufacture NECVAX-NEO1 at Heidelberg Facility
NEC Bio Therapeutics, a German biotechnology firm based in Mannheim, is collaborating with AGC Biologics to enhance the production of NECVAX-NEO1. This vaccine, designed to…
NEC Bio Therapeutics, a German biotechnology firm based in Mannheim, is collaborating with AGC Biologics to enhance the production of NECVAX-NEO1. This vaccine, designed to…
Essential Pharma has entered into a strategic agreement with AGC Biologics for the production of Hu14.18, a humanized monoclonal antibody. This antibody is currently under development…
AGC Biologics, a global biopharmaceutical CDMO, and BioConnection, a specialised contract manufacturing organisation (CMO), have announced a new partnership to provide comprehensive biopharmaceutical development and…
AGC Biologics, a Seattle-based biopharma contract manufacturer, has announced plans to lay off just under 4% of its global workforce. The company, which employs more…
AGC Biologics, a biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Milan site…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.